Fate Therapeutics (FATE) Asset Utilization Ratio (2013 - 2026)

Fate Therapeutics' Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.02 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 34.16% year-over-year to 0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02 (down 34.16% YoY) and the FY2025 annual result came in at 0.02, down 39.22% from the prior year.
• Asset Utilization Ratio was 0.02 for Q1 2026 at Fate Therapeutics, up from 0.02 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.2 in Q1 2023 and bottomed at 0.01 in Q1 2024.
• A 5-year average of 0.08 and a median of 0.03 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio jumped 188.89% — and 2024, when it tumbled 94.12%.
• Fate Therapeutics' Asset Utilization Ratio stood at 0.13 in 2022, then decreased by 8.58% to 0.12 in 2023, then sank by 75.92% to 0.03 in 2024, then sank by 31.15% to 0.02 in 2025, then grew by 4.28% to 0.02 in 2026.
• Business Quant data shows FATE's Asset Utilization Ratio at 0.02 in Q1 2026, 0.02 in Q4 2025, and 0.02 in Q3 2025.